Activin A: A potential therapeutic target for characterizing and stopping joint pain early in rheumatoid arthritis patients

Inflammation

Volumn 37, Issue 1, 2014, Pages 170-176

  Dong, Fei ^a   He, Xijing ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

activin A; early rheumatoid arthritis; joint pain; macrophage; synovitis

Indexed keywords

ACTIVIN A;

ARTHRALGIA; DISEASE COURSE; INFLAMMATION; REVIEW; RHEUMATOID ARTHRITIS; SYNOVITIS;

ACTIVINS; ANIMALS; ARTHRALGIA; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGE ACTIVATION; MACROPHAGES; MICE; RATS; SYNOVIAL FLUID; SYNOVIAL MEMBRANE; SYNOVITIS;

EID: 84900350045     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9727-7     Document Type: Review

References (59)

1. Kvien, T.K. 2004. Epidemiology and burden of illness of rheumatoid arthritis. PharmacoEconomics 22(1): 1-12. (Pubitemid 38269929)
2. Smith, H.S., A.R. Smith, and P. Seidner. 2011. Painful rheumatoid arthritis. Pain Physician 14(5): E427-E458.
3. Heiberg, T., A. Finset, T. Uhlig, et al. 2005. Seven year changes in health status and priorities for improvement of health in patients with rhematoid arthritis. Annals of the Rheumatic Diseases 64: 191-195. (Pubitemid 40193610)
4. Strand, V., P. Emery, S. Fleming, et al. 2010. The impact of rheumatoid arthritis (RA) on women: focus on pain, productivity and relationships. Arthritis and Rheumatism 62(Suppl 10): 1063.
5. O' Dll, J.R. 2002. Treating rheumatoid arthritis early: a window of opportunity? Arthritis and Rheumatism 46(2): 283-285.
6. Nell, V.P.K., K.P. Machold, G. Eberl, et al. 2004. Benefit of very early referral and very early therapy with disease-modifying antirheumatic drugs in patients with early rheumatoid arthritis. Rheumatology 43(7): 906-914. (Pubitemid 38996967)
7. Finckh, A., M.H. Liang, C.M. van Herckenrode, et al. 2006. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: a meta-analysis. Arthritis and Rheumatism 55(6): 864-872. (Pubitemid 44917458)
8. Raza, K., C.E. Buckley, M. Salmon, et al. 2006. Treating very early rheumatoid arthritis. Best Practice and Research in Clinical Rheumatology 20(5): 849-863. (Pubitemid 44382383)
9. Mantovani, A., A. Sica, and M. Locati. 2007. New vistas on macrophage differentiation and activation. European Journal of Immunology 37(1): 14-16. (Pubitemid 46128780)
10. Chawla, A., K.D. Nguyen, and Y.S. Goh. 2011. Macrophage-mediated in fl ammation in metabolic disease. Nature Reviews Immunology 11(11): 738-749.
11. Ge, J., Y. Wang, Y. Feng, et al. 2009. Direct effects of activin A on the activation of mouse macrophage RAW264.7 cells. Cellular and molecular immunology 6(2): 129-133.
12. Xu, P., C. Van Slambrouck, L. Berti-Mattera, et al. 2005. Activin induces tactile allodynia and increases calcitonin gene-related peptide after peripheral inflammation. Journal of Neuroscience 25(40): 9227-9235. (Pubitemid 41500831)
13. Zhu, W., P. Xu, F.X. Cuascut, et al. 2007. Activin acutely sensitizes dorsal root ganglion neurons and induces hyperalgesia via PKC-mediated potentiation of transient receptor potential vanilloid 1. Journal of Neuroscience 27(50): 13770-13780. (Pubitemid 350278254)
14. Sierra-Filardi, E., A. Puig-Kröger, F.J. Blanco, et al. 2011. Activin A skews macrophage polarization by promoting a pro-inflammatory phenotype and inhibiting the acquisition of anti-inflammatory macrophage markers. Blood 117(19): 5092-5101.
15. Wang, Y., X. Cui, G. Tai, et al. 2009. A critical role of activin A in maturation of mouse peritoneal macrophages in vitro and in vivo. Cellular and molecular immunology 6(5): 387-392.
16. Yoshino, O., G. Izumi, J. Shi, et al. 2011. Activin A is induced by interleukin-1β and tumor necrosis factor-α and enhances the mRNA expression of interleukin-6 and protease-activated receptor-2 and proliferation of stromal cells from endometrioma. Fertility and Sterility 96(1): 118-121.
17. Nüsing, R.M., and J. Barsig. 1999. Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A. British Journal of Pharmacology 127(4): 919-926. (Pubitemid 29295351)
18. Ohguchi, M., K. Yamato, Y. Ishihara, et al. 1998. Activin A regulates the prodution of mature interleukin-1β and interleukin-1 receptor antagonist in human monocytic cells. Journal of Interferon & Cytokine Research 18(7): 491-498. (Pubitemid 28363576)
19. Sugama, S., T. Takenouchi, H. Kitani, et al. 2007. Activin as an antiinflammatory cytokine produced by microglia. Journal of Neuroimmunology 192(1): 31-39. (Pubitemid 350213114)
20. Ogawa, K., M. Funaba, Y. Chen, et al. 2006. Activin A functions as a Th2 cytokine in the promotion of the alternative activation of macrophages. Journal of Immunology 177(10): 6787-6794. (Pubitemid 44715043)
21. Chang, D.M., S.H. Liu, H.S. Lee, et al. 2007. Activin A suppress interleukin-1-induced matrix metalloproteinase 3 secretion in human chondrosarcoma cells. Rheumatology International 27(11): 1049-1055.
22. Yu, E.W., K.E. Dolter, L.E. Shao, et al. 1998. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clinical and Experimental Immunology 112(1): 126-132. (Pubitemid 28157109)
23. Li, N., X. Cui, J. Ge, et al. 2013. Activin A inhibits activities of lipopolysaccharide-activated macrophages via TLR-4, not of TLR2. Biochemical and Biophysical Research Communications 435(2): 222-228.
24. Zhang, X.J., Y. Li, G.X. Tai, et al. 2005. Effects of activin A on the activities of mouse peritoneal macrophages. Cellular and molecular immunology 2(1): 63-67.
25. MaGonagle, D., W. Gibbon, and P. Emery. 1998. Classification of inflammatory arthritis by enthesitis. Lancet 352(9134): 1137-1140.
26. Scott, D.L. 2000. Prognostic factors in early rheumatoid arthritis. Rheumatology (Oxford, England) 39: 24.
27. Detert J, Bastian H, Listing J, et al. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naïve patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study. Annals of the Rheumatic Diseases. 2013;72(6):844-850
28. El-Gendi, S.S., A.E. Moniem, N.M. Tawfik, et al. 2010. Value of serum and synovial fluid activin A and inhibin A in some rheumatic diseases. International Journal of Rheumatic Diseases 13(3): 273-279.
29. Ota, F., A. Maeshima, S. Yamashita, et al. 2003. Activin A induces cell proliferation of fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis and Rheumatism 48(9): 2442-2449. (Pubitemid 37129421)
30. Jones, K.L., J.N. Brauman, N.P. Groome, et al. 2000. Activin A release into the circulation is an early event in systemic in flammation and precedes the release of follistatin. Endocrinology 141(5): 1905-1908. (Pubitemid 32274422)
31. Sozzani, S., and T. Musso. 2011. The yin and yang of activin A. Blood 117(19): 5013-5015.
32. Jones, K.L., D.M. de Kretser, I.J. Clarke, et al. 2004. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. Journal of Endocrinology 182(1): 69-80. (Pubitemid 39076903)
33. Jones, K.L., A. Mansell, S. Patella, et al. 2007. Activin A is a critical component of the inflammatory response, and its binding protein, follitatin, reduces morality in endotoxemia. Proceedings of The National Academy of Sciences of The United States of America 104(41): 16239-16244. (Pubitemid 350099391)
34. Munz, B., H. Smola, F. Engelhardt, et al. 1999. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO Journal 18(19): 5205-5215. (Pubitemid 29465571)
35. Haringman, J.J., D.M. Gerlag, A.H. Zwinderman, et al. 2005. Synovial tissue macrophages: a sensitive biomarker for response to treatment in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 64: 834-838. (Pubitemid 40733904)
36. Mclnnes, L.B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. The New England Journal of Medicine 365(23): 2205-2219.
37. Szekanecz, Z., and A.E. Koch. 2007. Macrophages and their products in rheumatoid arthritis. Current Opinion in Rheumatology 19(3): 289-295. (Pubitemid 46597469)
38. Ma, Y., and R.M. Pope. 2005. The role of macrophages in rheumatoid arthritis. Current Pharmaceutical Design 11(5): 569-580. (Pubitemid 40277869)
39. Choy, E.H., and G.S. Panayi. 2001. Cytokine pathways and joint inflammation in rheumatoid arthritis. The New England Journal of Medicine 344(12): 907-916. (Pubitemid 32224400)
40. Escribese, M.M., E. Sierra-Filardi, C. Nieto, et al. 2012. The prolyl hydroxylase PHD3 identifies pro-inflammatory macrophages and its expression is regulated by activin A. Journal of Immunology 189(4): 1946-1954.
41. Nüsing, R.M., S. Mohr, and V. Ullrich. 1995. Activin A and retinoic acid synergize in cyclooxygenase-1 and thromboxane synthase induction during differentiation of J774.1 macrophages. European Journal of Biochemistry 227(1-2): 130-136.
42. Nakagawa, N., H. Yokoyama, S. Matsuda, et al. 2011. Short-term outcome of finger joint synovectomy in rheumatoid arthritis. Modern Rheumatology 21(6): 598-601.
43. Furia, J.P. 2010. Anthroscopic debridement and synovectomy for treating basal joint arthritis. Arthroscopy: The Journal of Arthroscopic & Related Surgery 26(1): 34-40.
44. Tsuchida, K., M. Nakatani, K. Hitachi, et al. 2009. Activin signaling as an emerging target for therapeutic interventions. Cell Communication and Signaling 7: 15.
45. Chen, Y., H.Wu,W.R.Winnall, et al. 2011. Tumor necrosis factor-α stimulates human neutrophils to release preformed activin A. Immunology and Cell Biology 89(8): 889-896.
46. Olsson, N., E. Piek, P. ten Dijke, et al. 2000. Human mast cell migration in response to members of the transforming growth factor-beta family. Journal of Leukocyte Biology 67(3): 350-356.
47. Munz, B., G. Hubner, Y. Tretter, et al. 1999. A novel role of activin in in flammation and repair. Journal of Endocrinology 161(2): 187-193. (Pubitemid 29244244)
48. Ai, X., J. Cappuzzello, and A.K. Hall. 1999. Activin and bone morphogenetic proteins induce calcitonin gene-related peptide in embryonic sensory neurons in vitro. Molecular and Cellular Neurosciences 14(6): 506-518. (Pubitemid 30026591)
49. Hall, A.K., R.M. Burke, M. Anand, et al. 2002. Activin and bone morphogenetic proteins are present in perinatal sensory neuron target tissues that induce neuropeptides. Journal of Neurobiology 52(1): 52-60. (Pubitemid 34666129)
50. Xu, P., and A.K. Hall. 2007. Activin acts with nerve growth factor to regulate calcitonin gene-related peptide mRNA in sensory neurons. Neuroscience 150(3): 665-674. (Pubitemid 350198735)
51. Fang, L., Y.N. Wang, X.L. Cui, et al. 2012. The role and mechanism of action of activin A in neurite outgrowth of chicken embryonic dorsal root ganglia. Journal of Cell Science 125(6): 1500-1507.
52. +-ATPase. Neuron 69: 974-987.
53. Zhang, F.X., X.J. Liu, L.Q. Gong, et al. 2010. Inhibition of inflammatory pain by activating B-type natriuretic peptide signal pathway in nociceptive sensory neurons. Journal of Neuroscience 30: 10927-10938.
54. Li, K.C., F. Wang, Y.Q. Zhong, et al. 2011. Reduction of follistatinlike 1 in primary afferent neurons contributes to neuropathic pain hypersensitivity[J]. Cell Research 21(4): 697-699.
55. Bhave, G., and R.W. Gereau. 2004. Posttranslational mechanisms of peripheral sensitization. Journal of Neurobiology 61(1): 88-106. (Pubitemid 39287772)
56. Patapoutian, A., S. Tate, and C.J. Woolf. 2009. Transient receptor potential channels: targeting pain at the source. Nature Reviews Drug Discovery 8(1): 55-68.
57. Liu, X.J., F.X. Zhang, H. Liu, et al. 2012. Activin C expressed in nociceptive afferent neurons is required for suppressing inflammatory pain. Brain 135(2): 391-403.
58. Kawasaki, Y., T. Kohno, Z.Y. Zhuang, et al. 2004. Ionotropic and metabotropic receptors, protein kinase A, protein kinase C, and Src contribute to C fiber-induced ERK activation and cAMP response element-binding protein phosphorylation in dorsal horn neurons, leading to central sensitization. Journal of Neuroscience 24: 8310-8321. (Pubitemid 39280810)
59. Hess, A., R. Axmann, J. Rech, et al. 2011. Blockade of TNF-α rapidly inhibits pain responses in the central nervous system. Proceedings of The National Academy of Sciences of The United States of America 108(9): 3731-3736.